Ben Stephens

Ben brings to Sitryx 25 years’ experience of board level, operational and finance roles within the pharmaceutical and industrial sectors. Over the past decade, Ben has worked across pharmaceutical, drug development and licensing fields, with university spin-outs from the UK’s leading institutions, healthcare start-ups and clinical stage biotechnology companies. These include as Finance Director at Rinri Therapeutics, a company developing first-in-class regenerative cell therapies for hearing loss, and Finance Director at nanovesicle platform company, ViaNautis Bio. Ben holds a BSc in Management Sciences from the University of Warwick and is a Fellow of the Chartered Institute of Management Accountants.